中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2010年
2期
119-121
,共3页
张启瑜%陶崇林%朱千东%周蒙滔%廖毅%余正平%施红旗
張啟瑜%陶崇林%硃韆東%週矇滔%廖毅%餘正平%施紅旂
장계유%도숭림%주천동%주몽도%료의%여정평%시홍기
高血压,门静脉%远端脾肾分流术%脾动脉%疗效
高血壓,門靜脈%遠耑脾腎分流術%脾動脈%療效
고혈압,문정맥%원단비신분류술%비동맥%료효
Hypertension portal%Distal splenorenal shunt%Splenic artery
目的 探讨选择性脾胃区减断分流术治疗肝硬化门静脉高压症的临床应用.方法 2000年9月至2008年6月间采用选择性脾胃区减断分流术治疗门静脉高压症44例.其中29例随访12~85个月,平均44个月.结果 (1)无术中大出血和病死病例,区域性减压显著;(2)术后近期轻度脾梗塞3例,并发乳糜漏3例;(3)近期肝性脑病发生率2.27%(1/44),再发出血率0%;远期肝性脑病发生率3.45%(1/29),再发出血率3.45%(1/29);(4)远期脾脏显著缩小,血小板显著升高(P<0.01).结论 选择性脾胃区减断分流术疗效可靠,可作为治疗门静脉高压症的理想术式.
目的 探討選擇性脾胃區減斷分流術治療肝硬化門靜脈高壓癥的臨床應用.方法 2000年9月至2008年6月間採用選擇性脾胃區減斷分流術治療門靜脈高壓癥44例.其中29例隨訪12~85箇月,平均44箇月.結果 (1)無術中大齣血和病死病例,區域性減壓顯著;(2)術後近期輕度脾梗塞3例,併髮乳糜漏3例;(3)近期肝性腦病髮生率2.27%(1/44),再髮齣血率0%;遠期肝性腦病髮生率3.45%(1/29),再髮齣血率3.45%(1/29);(4)遠期脾髒顯著縮小,血小闆顯著升高(P<0.01).結論 選擇性脾胃區減斷分流術療效可靠,可作為治療門靜脈高壓癥的理想術式.
목적 탐토선택성비위구감단분류술치료간경화문정맥고압증적림상응용.방법 2000년9월지2008년6월간채용선택성비위구감단분류술치료문정맥고압증44례.기중29례수방12~85개월,평균44개월.결과 (1)무술중대출혈화병사병례,구역성감압현저;(2)술후근기경도비경새3례,병발유미루3례;(3)근기간성뇌병발생솔2.27%(1/44),재발출혈솔0%;원기간성뇌병발생솔3.45%(1/29),재발출혈솔3.45%(1/29);(4)원기비장현저축소,혈소판현저승고(P<0.01).결론 선택성비위구감단분류술료효가고,가작위치료문정맥고압증적이상술식.
Objective To evaluate the curative effect of selective decongestive devascularization shunt of gastrosplenic region(SDDS-GSR) for the treatment of portal hypertension. Methods From September 2000 to June 2008, 44 patients with portal hypertension had received SDDS-GSR in our hospital. Twenty-nine of them had been followed up for 12-85 months (mean=44months). Results Operative mortality was 0 %. Mesenteric area pressure(33.82±5.12 cm H_2O) was higher than splenic area pressure(24.57±4.63 cm H_2O)soon after the operation finished(P<0.01). No re-bleeding ca-ses were found, and the encephalopathy occurred in 2.27% of the patients in the early stage of post-operation. However, the rates of 3.45% for re-bleeding and 3.45% for encephalopathy were noticed in long-term follow-up. The 1-, 3- and 5-year survival were 100%, 95% and 95%, respectively. Dur-ing the long-term follow-up, the platelet counts markedly increased from (49.2±21.8 × 10~9/L) of preoperative value to (77.2±29.5×10~9/L) (P<0.01), while spleen size was significantly reduced.Conclusion SDDS-GSR is a reliable and reasonable surgical procedure for the management of portal hypertension.